Printer Friendly
The Free Library
14,505,807 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Me too drugs.


In "Trial and Error" (October), Merrill Goozner criticizes the idea that FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval be denied to any drug that offers trivial advantages over drugs already available, but he fails to suggest two strong criticisms: One, a "me too" drug can offer competition to a similar drug even though it isn't a generic equivalent. For example, most patients with high cholesterol Cholesterol, High Definition

Cholesterol is a fatty substance found in animal tissue and is an important component to the human body. It is manufactured in the liver and carried throughout the body in the bloodstream.
 can be treated with any of the commonly prescribed "statin stat·in
n.
Any of a class of drugs that inhibit a key enzyme involved in the synthesis of cholesterol and promote receptor binding of LDL cholesterol, resulting in decreased levels of serum cholesterol.
" drugs, though some are stronger than others. And it several drugs are available, there are alternatives it one turns out to cause problems that show up only after a few years on the market. Baycol, a "statin" that has been withdrawn, is one example--patients could easily switch to other medicines.

I agree that the pharmaceutical industry spends a lot of money developing "me too" drugs and even more promoting them, but I value having choices within a class of drugs.

David Grant, M.D.

San Antonio, Texas “San Antonio” redirects here. For other uses, see San Antonio (disambiguation).
San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S.
 
COPYRIGHT 2004 Washington Monthly Company
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters
Author:Grant, David
Publication:Washington Monthly
Article Type:Letter to the Editor
Date:Dec 1, 2004
Words:157
Previous Article:Small time lawyers.(Letters)(Letter to the Editor)
Next Article:Editor's note.



Related Articles
Karen Harrington named publisher at WBII, following founding publisher David Swit's death.
There's No Such Thing as Recreational Drugs.(Brief Article)
BIOTECH STOCKS RISE 68.4% TO END 3-YEAR SLUMP\Approvals, successful drug trials fueling industry growth, analysts\say.(BUSINESS)(Statistical Data...
Doctors receive warning about mifepristone. (FYI).(Brief Article)
Letters Log.(Letters)(Letter to the Editor)
"Arsenic in food": opinion parading as science.(Correspondence)(Letter to the Editor)
Herbal interaction with warfarin.(Letter to the Editor)
BRIEFCASE.(Business)
Letter Publications acquires Criminal Justice Funding Report from Congressional Digest.(Brief article)
Forbidden fruit: the FDA's war on cherries.(Food and Drug Administration's John King)(Brief article)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles